Delivery Order SPE2DX15D8001-SPE2DX24FBQCE
Award Date
11/30/23
Potential Completion Date
12/21/23
Potential Value
$1.8K
Federal Agency
Medical Supply Chain
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $3,611.72 firm fixed-price contract is for the delivery of PROQUAD vials, a pharmaceutical product, with a performance period through August 7, 2024. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the agency's ECAT Generation V Program, which enables the company to provide a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract has a ceiling value of $7,223.40 and a performance period through December 17, 2024. It is not associated with a set-aside program. The contract is for the delivery of PROQUAD VIALS, a type of pharmaceutical product, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. has a significant single-award...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,755.73, is for the delivery of PROQUAD VIALS, a pharmaceutical product. The contract is a firm-fixed-price Delivery Order with a period of performance through May 2, 2023. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is valued at $1,755.73 and covers the delivery of PROQUAD VIALS, a type of pharmaceutical product, to support military medical operations. The contract is not set aside and is awarded under Dakota Drug, Inc.'s existing Indefinite Delivery Contract (IDC) with the DLA,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of PROQUAD VIALS. The fixed-price contract has a ceiling value of $5,162.20 and a performance period through August 22, 2022. Dakota Drug, Inc. has a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the ECAT Generation V Program to provide a range of pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $3,611.72 firm fixed-price delivery order is for the provision of PROQUAD VIALS, a pharmaceutical product, to support U.S. Armed Forces medical operations. The contract is associated with Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA,...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of PROQUAD vials. The $2,580.94 contract has an ultimate completion date of January 17, 2023. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) as part of the DLA's ECAT Generation V Program, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $3,231.24 firm fixed-price delivery order is for the supply of PROQUAD VIALS, a pharmaceutical product, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC), valued at $999,999,999.00, with the DLA as part of the ECAT Generation V...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Dakota Drug, Inc. The contract is valued at $1,805.85 and covers the delivery of PROQUAD VIALS, a pharmaceutical product, to support the medical supply chain operations for the U.S. Armed Forces. The contract has a performance period ending on May 16, 2024. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit...
This is a firm fixed-price delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of PROQUAD VIALS, a pharmaceutical product, with a ceiling value of $1,805.85 and a period of performance through July 3, 2024. The contract was awarded on June 11, 2024 and does not have a set-aside designation. Dakota Drug, Inc. is a for-profit subchapter S corporation that...